Press Release

Morgan Lewis Advises Tabula Rasa HealthCare in $325M Rule 144A Convertible Note Offering

February 14, 2019

PHILADELPHIA, February 14, 2019: Morgan Lewis recently represented healthcare technology company Tabula Rasa HealthCare (Nasdaq: TRHC) in connection with its offering of $325 million principal amount of 1.75% convertible senior subordinated notes due 2026. The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.

Partners James McKenzie and Tom D’Ambrosio and associates Lauren Galbraith and Jackie Hamilton led the Morgan Lewis team advising Tabula Rasa HealthCare.